Annovis Bio Inc. (ANVS) option IV into data

Annovis Bio Inc. (NYSE: ANVS) 30-day option implied volatility is at 333; compared to its 52-week range of 21 to 333 into topline efficacy data for phase II/III study of buntanetap in patients with mild to moderate Alzheimer's disease is expected in April.

You May Also Be Interested In

• Steel Dynamics (STLD) call put ratio 2.8 calls to 1 put into quarter results
• Domino's Pizza (DPZ) call put ratio 1 call to 2 puts with a focus on August puts into quarter results
• Check Point Software Technology (CHKP) call put ratio 2.7 calls to 1 put with a focus on December 190 calls